Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cost Effectiveness in the US? Round One Goes Against Pharma

Apr 01 2009

• By Michael McCaughan

Related Content

FDA's Jesse Goodman is Rising Star Within Agency

Apr 01 2009

The Last Shall be First? The Federal Coordinating Committee for Comparative Effectiveness Research

Apr 01 2009

The Avastin Dilemma: Two Personalities and Two Points of View on Cost Effectiveness

Apr 01 2009

National Priorities for Comparative Effectiveness Research

Feb 01 2009

The Value Proposition: Why Pharma Should Embrace Comparative Effectiveness

Feb 01 2008

Additional Topics

Regulation Reimbursement BioPharmaceutical

More from Market Access

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window